Widimský P - Search Results

1

Randomized comparison of endothelial progenitor cells capture stent versus cobalt-chromium stent for treatment of ST-elevation myocardial infarction. Six-month clinical, angiographic, and IVUS follow-up.

Bystroň M, Cervinka P, Spaček R, Kvašňák M, Jakabčin J, Cervinková M, Kala P, Widimský P. Bystroň M, et al. Among authors: widimsky p. Catheter Cardiovasc Interv. 2010 Nov 1;76(5):627-31. doi: 10.1002/ccd.22612. Catheter Cardiovasc Interv. 2010. PMID: 20506282 Clinical Trial.

2

Value of first day angiography/angioplasty in evolving Non-ST segment elevation myocardial infarction: an open multicenter randomized trial. The VINO Study.

Spacek R, Widimský P, Straka Z, Jiresová E, Dvorák J, Polásek R, Karel I, Jirmár R, Lisa L, Budesínský T, Málek F, Stanka P. Spacek R, et al. Among authors: widimsky p. Eur Heart J. 2002 Feb;23(3):230-8. doi: 10.1053/euhj.2001.2735. Eur Heart J. 2002. PMID: 11792138 Clinical Trial.

3

Interhospital transport for primary angioplasty improves the long-term outcome of acute myocardial infarction compared with immediate thrombolysis in the nearest hospital (one-year follow-up of the PRAGUE-1 study).

Bednár F, Widimský P, Krupicka J, Groch L, Aschermann M, Zelízko M; PRAGUE Study Group Investigators. Bednár F, et al. Among authors: widimsky p. Can J Cardiol. 2003 Sep;19(10):1133-7. Can J Cardiol. 2003. PMID: 14532938 Clinical Trial.

4

Prevalence of normal coronary angiography in the acute phase of suspected ST-elevation myocardial infarction: experience from the PRAGUE studies.

Widimsky P, Stellova B, Groch L, Aschermann M, Branny M, Zelizko M, Stasek J, Formanek P; PRAGUE Study Group Investigators. Widimsky P, et al. Can J Cardiol. 2006 Nov;22(13):1147-52. doi: 10.1016/s0828-282x(06)70952-7. Can J Cardiol. 2006. PMID: 17102833 Free PMC article.

5

The impact of gender on outcomes of patients with ST elevation myocardial infarction transported for percutaneous coronary intervention: analysis of the PRAGUE-1 and 2 studies.

Motovska Z, Widimsky P, Aschermann M; PRAGUE Study Group Investigators. Motovska Z, et al. Among authors: widimsky p. Heart. 2008 Mar;94(3):e5. doi: 10.1136/hrt.2006.110866. Epub 2007 Aug 10. Heart. 2008. PMID: 17693459

6

Near-normal coronary angiography in a patient, who is entirely asymptomatic 24 years after successful intracoronary thrombolysis for ST elevation myocardial infarction. Follow-up of the historically first Czech intracoronary thrombolysis patient.

Widimsky P, Knot J. Widimsky P, et al. Acute Card Care. 2007;9(4):239-42. doi: 10.1080/17482940701441782. Acute Card Care. 2007. PMID: 17851974

7

Clopidogrel pre-treatment in stable angina: for all patients > 6 h before elective coronary angiography or only for angiographically selected patients a few minutes before PCI? A randomized multicentre trial PRAGUE-8.

Widimsky P, Motovská Z, Simek S, Kala P, Pudil R, Holm F, Petr R, Bílková D, Skalická H, Kuchynka P, Poloczek M, Miklík R, Maly M, Aschermann M; PRAGUE-8 Trial Investigators. Widimsky P, et al. Eur Heart J. 2008 Jun;29(12):1495-503. doi: 10.1093/eurheartj/ehn169. Epub 2008 Apr 25. Eur Heart J. 2008. PMID: 18441320 Free PMC article. Clinical Trial.

8

Next day discharge after successful primary angioplasty for acute ST elevation myocardial infarction. An open randomized study "Prague-5".

Jirmár R, Widimský P, Capek J, Hlinomaz O, Groch L. Jirmár R, et al. Among authors: widimsky p. Int Heart J. 2008 Nov;49(6):653-9. doi: 10.1536/ihj.49.653. Int Heart J. 2008. PMID: 19075481 Free article. Clinical Trial.

9

Optimal pretreatment timing for high load dosing (600 mg) of clopidogrel before planned percutaneous coronary intervention for maximal antiplatelet effectiveness.

Motovska Z, Widimsky P, Petr R, Bilkova D, Marinov I, Simek S, Kala P. Motovska Z, et al. Among authors: widimsky p. Int J Cardiol. 2010 Oct 8;144(2):255-7. doi: 10.1016/j.ijcard.2009.01.017. Epub 2009 Feb 15. Int J Cardiol. 2010. PMID: 19232444

10

Factors influencing clopidogrel efficacy in patients with stable coronary artery disease undergoing elective percutaneous coronary intervention: statin's advantage and the smoking "paradox".

Motovska Z, Widimsky P, Petr R, Bilkova D, Marinov I, Simek S, Kala P; PRAGUE-8 Study Investigators. Motovska Z, et al. Among authors: widimsky p. J Cardiovasc Pharmacol. 2009 May;53(5):368-72. doi: 10.1097/FJC.0b013e31819d616b. J Cardiovasc Pharmacol. 2009. PMID: 19247187 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

480 results

Search Page